Acadia Pharmaceuticals
Tracked across 4 events · 25 articles · First seen Jun 16, 2026 · Last active Sep 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Acadia Pharmaceuticals Inc. received a positive opinion from the CHMP for DAYBU, which could lead to its approval in the EU, significantly boosting the company's market position and revenue potential.
Jun 26, 2026 · 6 articles
Regulatory
Impact: Acadia is the developer and marketer of DAYBU. The EU approval expands its market and strengthens its rare disease franchise, supporting its long-term growth targets.
Aug 24, 2026 · 7 articles
Business
Impact: Acadia Pharmaceuticals is mentioned as Ridloff's former employer, where she raised $600 million in capital.
Aug 10, 2026 · 6 articles
Accidents
Two 24-year-old friends, Malaika Chitre of Dayton, New Jersey, and Navam Kaul of Sayreville, New Jersey, were fatally struck by a southbound No. 4 train at the Spring Street subway station in Lower Manhattan in…
Impact: One of the two victims, Malaika Chitre, worked as an operations specialist at Acadia Pharmaceuticals; the company faces no operational or financial impact from the accident.
Sep 15, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Acadia Pharmaceuticals live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard